Company intelligence / Profile preview

PANSS Institute

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

PANSS Institute advances the validity, reliability, and adoption of the Positive and Negative Syndrome Scale through training, standardization, and distribution partnerships. They support global clinical trials and psychiatric research by providing education, best practice resources, and facilitating licensing for commercial and academic use.

Therapeutic areas: NeurologyPsychiatry
Modalities: Non-pharmacological therapy (PANSS is an assessment tool, not a therapeutic modality)Specialty: Psychiatric rating scale and psychometric assessment
Industry: Drug Discovery Services

Partnerships

Mapi Research Trust (exclusive licensing/distribution partner for PANSS and derivative instruments)

Beyond the preview

Go deeper on PANSS Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PANSS Institute.

Explore the full profile